AIDS United explains the importance of three Supreme Court decisions, which the group views as two wins and a loss.

A recent study analyzed smoking’s ties to substance use and mental, psychological and general health in sexual minority men and trans women.

A similar training program, ESCALATE, will teach communities to recognize and fight HIV stigma.

The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.

Cabotegravir injections given every eight weeks as PrEP are even more effective than daily Truvada.

Supreme Court decisions and a Trump pronouncement on health care affect HIV efforts

Researchers ran a Gallup poll of HIV-negative transgender people to assess their risk of HIV, familiarity with PrEP and other factors.

We asked participants and presenters at the #AIDS2020Virtual what was compelling to them about the gathering. Here are their responses.

The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.

The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.